Company intelligence / Profile preview

Xenoma

Ownership: Private
Development stage: Other

Overview

Xenoma has developed and commercialized wearable smart apparel using its proprietary e-skin technology. Their products enable continuous home-based medical data collection such as ECG monitoring for cardiovascular disease prevention. The company is focused on enabling preventive medicine through user-friendly, machine-washable sensor garments that provide actionable health insights to individuals and healthcare professionals. Clinical results are not applicable in the traditional sense as the products are devices rather than therapeutics.

Therapeutic areas: CardiovascularOther
Modalities: DeviceNon-pharmacological therapy (wearable health monitoring)
Industry: Physiological Monitoring

Partnerships

Ono Pharmaceutical Co., Ltd.EPS Holdings, Inc. (CRO partner)

Beyond the preview

Go deeper on Xenoma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xenoma.

Explore the full profile